ERα-Dependent E2F Transcription Can Mediate Resistance to Estrogen Deprivation in Human Breast Cancer

Overview of attention for article published in Cancer Discovery, September 2011

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

policy: 1 policy source
patent: 22 patents

f1000: 1 research highlight platform

Readers on

mendeley: 187 Mendeley

So far, Altmetric has seen 22 patents that reference this research output.

Combination therapy using ribociclib and an aromatase inhibitor for the treatment of HR…

Grant US-12544380-B2

United States of America

10 Feb 2026

Combination therapy using ribociclib and fulvestrant for the treatment of HR+ breast…

Grant US-12544379-B2

United States of America

10 Feb 2026

COMBINATION THERAPY FOR CANCER TREATMENT

N/A RU-2805145-C2

Russian Federation

11 Oct 2023

Pharmaceutical compositions of amorphous solid dispersions and methods of preparation…

Grant US-11471418-B2

United States of America

18 Oct 2022

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 18 additional patents.